Skip Fleshman

Contributed: Trials and tribulations – the new world of decentralized trials
By Skip Fleshman | 12:19 pm | January 22, 2021
Asset Management Ventures' Skip Fleshman outlines COVID-19's impact on clinical trials and the resulting leap toward tech-enabled decentralized trials.